289 related articles for article (PubMed ID: 16563633)
1. Catalase-peroxidase of Mycobacterium bovis BCG converts isoniazid to isonicotinamide, but not to isonicotinic acid: differentiation parameter between enzymes of Mycobacterium bovis BCG and Mycobacterium tuberculosis.
Kang SK; Lee JH; Lee YC; Kim CH
Biochim Biophys Acta; 2006 May; 1760(5):724-9. PubMed ID: 16563633
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of Mycobacterium tuberculosis KatG, KatG(S315T), and Mycobacterium bovis KatG(R463L).
Wengenack NL; Lane BD; Hill PJ; Uhl JR; Lukat-Rodgers GS; Hall L; Roberts GD; Cockerill FR; Brennan PJ; Rodgers KR; Belisle JT; Rusnak F
Protein Expr Purif; 2004 Aug; 36(2):232-43. PubMed ID: 15249045
[TBL] [Abstract][Full Text] [Related]
3. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance.
Rouse DA; DeVito JA; Li Z; Byer H; Morris SL
Mol Microbiol; 1996 Nov; 22(3):583-92. PubMed ID: 8939440
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants.
Mo L; Zhang W; Wang J; Weng XH; Chen S; Shao LY; Pang MY; Chen ZW
Microb Drug Resist; 2004; 10(4):269-79. PubMed ID: 15650370
[TBL] [Abstract][Full Text] [Related]
5. Correlation between isoniazid resistance and superoxide reactivity in mycobacterium tuberculosis KatG.
Ghiladi RA; Medzihradszky KF; Rusnak FM; Ortiz de Montellano PR
J Am Chem Soc; 2005 Sep; 127(38):13428-42. PubMed ID: 16173777
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomics reveals novel insights into isoniazid susceptibility in mycobacteria mediated by a universal stress protein.
Hu X; Li X; Huang L; Chan J; Chen Y; Deng H; Mi K
J Proteome Res; 2015 Mar; 14(3):1445-54. PubMed ID: 25664397
[TBL] [Abstract][Full Text] [Related]
7. Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.
Reingewertz TH; Meyer T; McIntosh F; Sullivan J; Meir M; Chang YF; Behr MA; Barkan D
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767723
[TBL] [Abstract][Full Text] [Related]
8. The tuberculosis prodrug isoniazid bound to activating peroxidases.
Metcalfe C; Macdonald IK; Murphy EJ; Brown KA; Raven EL; Moody PC
J Biol Chem; 2008 Mar; 283(10):6193-200. PubMed ID: 18056997
[TBL] [Abstract][Full Text] [Related]
9. Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance.
Yu S; Girotto S; Lee C; Magliozzo RS
J Biol Chem; 2003 Apr; 278(17):14769-75. PubMed ID: 12586821
[TBL] [Abstract][Full Text] [Related]
10. Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy.
Kapetanaki S; Chouchane S; Girotto S; Yu S; Magliozzo RS; Schelvis JP
Biochemistry; 2003 Apr; 42(13):3835-45. PubMed ID: 12667074
[TBL] [Abstract][Full Text] [Related]
11. Catalase-peroxidases (KatG) exhibit NADH oxidase activity.
Singh R; Wiseman B; Deemagarn T; Donald LJ; Duckworth HW; Carpena X; Fita I; Loewen PC
J Biol Chem; 2004 Oct; 279(41):43098-106. PubMed ID: 15280362
[TBL] [Abstract][Full Text] [Related]
12. Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis.
Wilson TM; de Lisle GW; Collins DM
Mol Microbiol; 1995 Mar; 15(6):1009-15. PubMed ID: 7623658
[TBL] [Abstract][Full Text] [Related]
13. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.
Zhang Y; Heym B; Allen B; Young D; Cole S
Nature; 1992 Aug; 358(6387):591-3. PubMed ID: 1501713
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid.
Wengenack NL; Uhl JR; St Amand AL; Tomlinson AJ; Benson LM; Naylor S; Kline BC; Cockerill FR; Rusnak F
J Infect Dis; 1997 Sep; 176(3):722-7. PubMed ID: 9291321
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the binding of isoniazid and analogues to Mycobacterium tuberculosis catalase-peroxidase.
Zhao X; Yu S; Magliozzo RS
Biochemistry; 2007 Mar; 46(11):3161-70. PubMed ID: 17309235
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the catalase-peroxidase KatG W78F mutant from Synechococcus elongatus PCC7942 in complex with the antitubercular pro-drug isoniazid.
Kamachi S; Hirabayashi K; Tamoi M; Shigeoka S; Tada T; Wada K
FEBS Lett; 2015 Jan; 589(1):131-7. PubMed ID: 25479089
[TBL] [Abstract][Full Text] [Related]
17. The crystal structure of isoniazid-bound KatG catalase-peroxidase from Synechococcus elongatus PCC7942.
Kamachi S; Hirabayashi K; Tamoi M; Shigeoka S; Tada T; Wada K
FEBS J; 2015 Jan; 282(1):54-64. PubMed ID: 25303560
[TBL] [Abstract][Full Text] [Related]
18. Catalase-peroxidase (Mycobacterium tuberculosis KatG) catalysis and isoniazid activation.
Chouchane S; Lippai I; Magliozzo RS
Biochemistry; 2000 Aug; 39(32):9975-83. PubMed ID: 10933818
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis.
Timmins GS; Master S; Rusnak F; Deretic V
Antimicrob Agents Chemother; 2004 Aug; 48(8):3006-9. PubMed ID: 15273113
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
